Zecuity® transdermal patch to treat migraine headaches approved by the FDA in 2013. IPO (NASDAQ: PATH) completed in August 2010 and the company was acquired by Teva Pharmaceutical Industries Ltd. in February 2014.
© 2024 BioAdvance. All Rights Reserved. | Privacy Policy | Site by Loudmark
101 West Elm Street, Suite 330, Conshohocken, PA 19428 | (610) 230-0544